prednisone,cyclophosphamide,rituximab,bendamustine,vincristine,doxorubicin,ibrutinib
janssen,abbvie
['selene']
selene unchanged overall survival forest plots don t reveal a group that derived substantial benefit similar lack of pfs benefit in mzl patients #17icml 
haematology registrar | @harvardmed fellow @PORTAL_research | evidence-based medicine & policy | lymphoma | myeloma | Fulbright | writer | SoMe Ed @BrJHaem